A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

NCT00536471 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

776

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Duloxetine hydrochloride
DRUG: Placebo

Sponsor

Eli Lilly and Company